Use of clomiphene citrate alone, urinary follicle-stimulating hormone alone, or both combined sequentially in patients with unexplained subfertility undergoing intrauterine insemination: A randomized trial
Author(s) -
Reyhan Ayaz,
Mehmet Reşit Asoğlu,
Selçuk Ayas
Publication year - 2018
Publication title -
journal of turkish society of obstetric and gynecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.41
H-Index - 9
eISSN - 1307-7007
pISSN - 1307-699X
DOI - 10.4274/tjod.99835
Subject(s) - infertility , randomized controlled trial , medicine , gynecology , artificial insemination , pregnancy , unexplained infertility , pregnancy rate , follicle stimulating hormone , obstetrics , hormone , biology , luteinizing hormone , genetics
To compare the successes of clomiphene citrate (CC) alone, pure human urinary follicle-stimulating hormone (uFSH) alone, and both combined sequentially in patients with unexplained subfertility couples undergoing intrauterine insemination (IUI).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom